Seratrodast
Seratrodast (ABT-001) is a selective thromboxane A2 receptor (TP) antagonist, first approved in Japan in 1997 for asthma therapy. It is widely used in respiratory disease research to investigate bronchoconstriction and inflammation mechanisms in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
112665-43-7
Product Name Alternative
Seratrodast, Prostaglandin Receptor, ProstaglandinReceptor, TXA2R, inhibit, Inhibitor, COX, AA 2414, AA2414, AA-2414, ABT001, ABT-001, ABT 001
Field of Research
Cell Biology, Immunology & Inflammation, Metabolism Research, Molecular Biology, Neuroscience, Pharmacology & Drug Discovery, Signal Transduction
Purity
>98%
Bioactivity
Thromboxane A2 receptor antagonist
Form
Powder
Solubility
DMSO:50 mg/mL (141.07 mM) ;10% DMSO+90% Saline:2.5 mg/mL (7.05 mM)
Smiles
C (CCCCCC (O) =O) (C1=C (C) C (=O) C (C) =C (C) C1=O) C2=CC=CC=C2
Molecular Formula
C22H26O4
Molecular Weight
354.44
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
GST-Tagged Recombinant Protein Purification Column
